Atomexetine (Atomaktin)
Atomexetine
Macleods Pharmaceuticals SA (Pty) Ltd
Registration
- Applicant
- Macleods Pharmaceuticals SA (Pty) Ltd
- Certificate holder
- Macleods Pharmaceuticals SA (Pty) Ltd
- Registrations
- 6
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Atomaktin 10 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10Capsule | 56114156/1.2/1141Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 18 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18Capsule | 56114256/1.2/1142Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 25 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg | 25Capsule | 56114356/1.2/1143Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 40 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40Capsule | 56114456/1.2/1144Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 60 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg | 60Capsule | 56114556/1.2/1145Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 80 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg | 80Capsule | 56114656/1.2/1146Approved 29 August 2025 | Registered | S5 | PIPIL |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
Schedule Verification
This medication's schedule (S5) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.